Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.
2.

[Angina pectoris in a 47-year-old athletic man with psoriasis vulgaris].

Braumann S, Peitsch WK, Pfister R, Michels G.

Internist (Berl). 2018 Sep 7. doi: 10.1007/s00108-018-0491-5. [Epub ahead of print] German.

PMID:
30194482
3.

The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts.

Recke A, Konitzer S, Lemcke S, Freitag M, Sommer NM, Abdelhady M, Amoli MM, Benoit S, El-Chennawy F, Eldarouti M, Eming R, Gläser R, Günther C, Hadaschik E, Homey B, Lieb W, Peitsch WK, Pföhler C, Robati RM, Saeedi M, Sárdy M, Sticherling M, Uzun S, Worm M, Zillikens D, Ibrahim S, Vidarsson G, Schmidt E; German AIBD Genetic Study Group.

Front Immunol. 2018 Aug 2;9:1788. doi: 10.3389/fimmu.2018.01788. eCollection 2018.

4.

Perichondritis am Ohr eines afghanischen Immigranten.

Almustafa ZZ, Sasama B, Peitsch WK.

J Dtsch Dermatol Ges. 2018 Apr;16(4):500-503. doi: 10.1111/ddg.13384_g. No abstract available.

PMID:
29645389
5.

Biologicals and small molecules in psoriasis: A systematic review of economic evaluations.

Kromer C, Celis D, Sonntag D, Peitsch WK.

PLoS One. 2018 Jan 3;13(1):e0189765. doi: 10.1371/journal.pone.0189765. eCollection 2018. Review.

6.

Perichondritis of the ear in an Afghan immigrant.

Almustafa ZZ, Sasama B, Peitsch WK.

J Dtsch Dermatol Ges. 2018 Apr;16(4):501-503. doi: 10.1111/ddg.13384. Epub 2017 Dec 6. No abstract available.

PMID:
29211334
7.

Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare).

Schaarschmidt ML, Herr R, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, Augustin M, Peitsch WK.

Acta Derm Venereol. 2018 Feb 7;98(2):200-205. doi: 10.2340/00015555-2834.

8.

Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability.

Kromer C, Peitsch WK, Herr R, Schmieder A, Sonntag D, Schaarschmidt ML.

J Dtsch Dermatol Ges. 2017 Feb;15(2):189-200. doi: 10.1111/ddg.12919.

PMID:
28214326
9.

Behandlungspräferenzen für Biologika bei Psoriasis: erfahrene Patienten legen Wert auf Nachhaltigkeit.

Kromer C, Peitsch WK, Herr R, Schmieder A, Sonntag D, Schaarschmidt ML.

J Dtsch Dermatol Ges. 2017 Feb;15(2):189-201. doi: 10.1111/ddg.12919_g.

PMID:
28214324
10.

Lupus Miliaris Disseminatus Faciei: Not Only a Facial Dermatosis.

Schaarschmidt ML, Schlich M, Staub J, Schmieder A, Goerdt S, Peitsch WK.

Acta Derm Venereol. 2017 May 8;97(5):655-656. doi: 10.2340/00015555-2616. No abstract available.

11.

Drug survival rates and reasons for drug discontinuation in psoriasis.

Arnold T, Schaarschmidt ML, Herr R, Fischer JE, Goerdt S, Peitsch WK.

J Dtsch Dermatol Ges. 2016 Nov;14(11):1089-1099. doi: 10.1111/ddg.13152.

PMID:
27879076
12.

"Drug-Survival"-Raten und Gründe für den Abbruch von Systemtherapien bei Psoriasis.

Arnold T, Schaarschmidt ML, Herr R, Fischer JE, Goerdt S, Peitsch WK.

J Dtsch Dermatol Ges. 2016 Nov;14(11):1090-1101. doi: 10.1111/ddg.13152_g. Erratum in: J Dtsch Dermatol Ges. 2017 Jan;15(1):110.

PMID:
27879071
13.

[Psoriasis in special localizations].

Schmieder A, Peitsch WK.

Hautarzt. 2016 Jun;67(6):454-63. doi: 10.1007/s00105-016-3806-2. Review. German.

PMID:
27215754
14.

Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.

Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Sonntag D, Goerdt S, Peitsch WK.

PLoS One. 2015 Dec 3;10(12):e0144335. doi: 10.1371/journal.pone.0144335. eCollection 2015.

15.

Association of Cole disease with novel heterozygous mutations in the somatomedin-B domains of the ENPP1 gene: necessary, but not always sufficient.

Schlipf NA, Traupe H, Gilaberte Y, Peitsch WK, Hausser I, Oji V, Schmieder A, Schneider SW, Demmer P, Rösler B, Fischer J.

Br J Dermatol. 2016 May;174(5):1152-6. doi: 10.1111/bjd.14328. Epub 2016 Feb 18. No abstract available.

PMID:
26617416
16.

Patient Preferences for Treatment of Basal Cell Carcinoma: Importance of Cure and Cosmetic Outcome.

Martin I, Schaarschmidt ML, Glocker A, Herr R, Schmieder A, Goerdt S, Peitsch WK.

Acta Derm Venereol. 2016 Mar;96(3):355-60. doi: 10.2340/00015555-2273.

17.

Associations between Merkel cell carcinoma and Merkel cell polyomavirus.

Peitsch WK.

Br J Dermatol. 2015 Jul;173(1):7-8. doi: 10.1111/bjd.13925. No abstract available.

PMID:
26174636
18.

Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment.

Kromer C, Schaarschmidt ML, Schmieder A, Herr R, Goerdt S, Peitsch WK.

PLoS One. 2015 Jun 9;10(6):e0129120. doi: 10.1371/journal.pone.0129120. eCollection 2015.

19.

Erythematous nodule on the earlobe in a patient from Iraq.

Linke M, Géraud C, Tobeigei F, Vogelmann R, Marx A, Goerdt S, Peitsch WK.

J Dtsch Dermatol Ges. 2015 Jun;13(6):588-90. doi: 10.1111/ddg.12579. Epub 2015 May 22. English, German. No abstract available.

PMID:
25997517
20.

Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population.

Hirose M, Schilf P, Benoit S, Eming R, Gläser R, Homey B, Kunz M, Nebel A, Peitsch WK, Pföhler C, Sárdy M, Schreiber S, Zillikens D, Schmidt E, Ibrahim SM; German AIBD Genetic Study Group.

Exp Dermatol. 2015 Sep;24(9):715-7. doi: 10.1111/exd.12732. Epub 2015 May 26. No abstract available.

PMID:
25941154

Supplemental Content

Loading ...
Support Center